Aptevo Therapeutics Inc.

APVONASDAQ Capital Market·USD·Closed

APVONASDAQ·USD·Closed

$4.72

−0.84%

$4.72

−$0.04 (0.84%)

52W Range

0thpctl

Volume

0.19×avg

Mkt Cap

10.32MUSD

P/E

-0.2TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

0thpctl

Volume

0.19×avg

Market Cap

10.32MUSD

P/E Ratio

-0.2TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-166.3%

Financially safe

Stretched

Debt / equity0.38×

Interest coverage0.0×

Current ratio3.36×

Continue with finqOS

Unlock the full picture

SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.

14-day free trial · No credit card required